Study reveals how live bacterial therapy reshapes the vaginal microbiome and identifies predictors of treatment success

A new study from the Kwon Lab at the Ragon Institute, published in Cell Host & Microbe, provides the most detailed picture yet of how a promising bacterial therapy works to prevent recurrent bacterial vaginosis (BV) and why it works better for some women than others.